(Q33438339)

26 July 2017

title

Effects on bowel motility of misoprostol administered before and after meals (English)

1 reference

26 July 2017

1 reference

1

Rutgeerts P

1 reference

26 July 2017

G. Vantrappen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1793784

27 November 2022

M. Hiele

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1793784

27 November 2022

Y. Ghoos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1793784

27 November 2022

C. Onkelinx

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1793784

27 November 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

full work available at URL

26 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1991.tb00522.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1991.tb00522.x/fullpdf

27 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Alimentary Pharmacology & Therapeutics

27 November 2022

published in

1 reference

26 July 2017

volume

5

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

533-542

1 reference

Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?

26 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Physiology and pharmacology of prostaglandins

27 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

SC-29333: a potent inhibitor of canin gastric secretion

27 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

The cytoprotective effects of (+/-)-15-deoxy-16-alpha, beta-hydroxy-16-methyl PGE1 methyl ester (sc-29333) versus aspirin-shock gastric ulcerogenesis in the dog

27 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate

27 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study

27 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study

27 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial

27 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients

27 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Overview of misoprostol clinical experience

27 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1

27 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.

27 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins

27 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin

27 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Effect of oral prostaglandin E1 on intestinal transit in man

27 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements

27 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Clean collection and manipulation of stools

27 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Polyethylene glycol as a quantitative fecal marker in human nutrition experiments,

27 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Polyethylene glycol 4000 as a continuously administered non-absorbable faecal marker for metabolic balance studies in human subjects

27 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

Effects of food and antacid on oral absorption of misoprostol, a synthetic prostaglandin E1 analog

27 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00522.X

27 November 2022

Identifiers

0 references

1 reference